Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Financings

QScreen arranges $500,000 private placement

QAI · Price

Executive Summary

  • QScreen AI Inc. has arranged a non-brokered private placement to raise up to $500,000 in gross proceeds.
  • The company intends to issue up to 10 million units at a price of $0.05 per unit.
  • Proceeds will be used to advance commercialization initiatives, including pilot discussions and operational integration, as well as to support working capital requirements.

Key Details

  • Transaction Structure: Non-brokered private placement.
  • Units Offered: Up to 10,000,000 units.
  • Price Per Unit: $0.05.
  • Gross Proceeds: Up to $500,000.
  • Unit Composition: Each unit consists of one common share and one-half of one common share purchase warrant.
  • Warrant Terms:
    • Each warrant entitles the holder to purchase one-half of a common share.
    • Exercise Price: $0.15 per half-share.
    • Term: 36 months following the closing date.
    • Acceleration Clause: If the volume-weighted average price (VWAP) of common shares on the Canadian Securities Exchange is equal to or greater than $0.30 for any 10 consecutive trading days (starting four months and one day after closing), the company may accelerate the warrant expiry date to 30 days following written notice to holders.
  • Use of Proceeds:
    • Advancing structured pilot discussions and operational integration planning with select organizations.
    • Supporting working capital requirements associated with scaling commercialization efforts across enterprise-scale health care, industrial, and technology sectors.
  • Market Interest: Preliminary indications of interest have been received from select investors.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from QScreen AI Inc